Literature DB >> 8392608

Inhibition of proteolytic activity of poliovirus and rhinovirus 2A proteinases by elastase-specific inhibitors.

A Molla1, C U Hellen, E Wimmer.   

Abstract

A polyprotein cleavage assay has been developed to assay the proteolytic activities in vitro of the 2A proteinases encoded by poliovirus and human rhinovirus 14, which are representative members of the Enterovirus and Rhinovirus genera of picornaviruses, respectively. The elastase-specific substrate-based inhibitors elastatinal and methoxysuccinyl-Ala-Ala-Pro-Val-chloromethylketone (MPCMK) inhibited both 2A proteinases in vitro. The electrophoretic mobilities of both 2A proteinases were reduced upon incubation with elastatinal, whereas the mobility of a Cys-109-->Ala poliovirus 2Apro mutant was unchanged, an observation suggesting that this inhibitor may have formed a covalent bond with the active-site Cys-109 nucleophile. Iodoacetamide, calpain inhibitor 1, and antipain inhibited poliovirus 2Apro. MPCMK caused a reduction in the yields of the enteroviruses poliovirus type 1 and coxsackievirus A21 and of human rhinovirus 2 in infected HeLa cells but did not affect the growth of encephalomyocarditis virus, a picornavirus of the Cardiovirus genus. MPCMK abrogated the shutoff of host cell protein synthesis that is induced by enterovirus and rhinovirus infection and reduced the synthesis of virus-encoded polypeptides in infected cells. These results indicate that the determinants of substrate recognition by 2A proteinases resemble those of pancreatic and leukocyte elastases. These results may be relevant to the development of broad-range chemotherapeutic agents against entero- and rhinoviruses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392608      PMCID: PMC237854     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Translational enhancement of the poliovirus 5' noncoding region mediated by virus-encoded polypeptide 2A.

Authors:  S J Hambidge; P Sarnow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

2.  Improved method for staining cell monolayers for virus plaque counts.

Authors:  J J HOLLAND; L C McLAREN
Journal:  J Bacteriol       Date:  1959-10       Impact factor: 3.490

3.  A collaborative report: rhinoviruses--extension of the numbering system from 89 to 100.

Authors:  V V Hamparian; R J Colonno; M K Cooney; E C Dick; J M Gwaltney; J H Hughes; W S Jordan; A Z Kapikian; W J Mogabgab; A Monto
Journal:  Virology       Date:  1987-07       Impact factor: 3.616

4.  Cleavage site between VP1 and P2A of human rhinovirus is different in serotypes 2 and 14.

Authors:  H Kowalski; I Maurer-Fogy; M Zorn; H Mischak; E Kuechler; D Blaas
Journal:  J Gen Virol       Date:  1987-12       Impact factor: 3.891

Review 5.  Inhibitors of leukocyte elastase and leukocyte cathepsin G. Agents for the treatment of emphysema and related ailments.

Authors:  W C Groutas
Journal:  Med Res Rev       Date:  1987 Apr-Jun       Impact factor: 12.944

6.  Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome.

Authors:  W M Lee; S S Monroe; R R Rueckert
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

7.  Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220.

Authors:  H G Kräusslich; M J Nicklin; H Toyoda; D Etchison; E Wimmer
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

8.  Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases.

Authors:  M J Nicklin; H G Kräusslich; H Toyoda; J J Dunn; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

Review 9.  Viral proteases as targets for chemotherapeutic intervention.

Authors:  C U Hellen; E Wimmer
Journal:  Curr Opin Biotechnol       Date:  1992-12       Impact factor: 9.740

10.  Cardioviral internal ribosomal entry site is functional in a genetically engineered dicistronic poliovirus.

Authors:  A Molla; S K Jang; A V Paul; Q Reuer; E Wimmer
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

View more
  28 in total

1.  Ex vivo and in vivo inhibition of human rhinovirus replication by a new pseudosubstrate of viral 2A protease.

Authors:  Nisrine Falah; Sébastien Violot; Didier Décimo; Fatma Berri; Marie-Laure Foucault-Grunenwald; Théophile Ohlmann; Isabelle Schuffenecker; Florence Morfin; Bruno Lina; Béatrice Riteau; Jean-Claude Cortay
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Selective Removal of FG Repeat Domains from the Nuclear Pore Complex by Enterovirus 2A(pro).

Authors:  Nogi Park; Nicholas J Schweers; Kurt E Gustin
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

3.  Dual inhibition of human rhinovirus 2A and 3C proteases by homophthalimides.

Authors:  Q M Wang; R B Johnson; L N Jungheim; J D Cohen; E C Villarreal
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

4.  Specific cleavage of the nuclear pore complex protein Nup62 by a viral protease.

Authors:  Nogi Park; Tim Skern; Kurt E Gustin
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

5.  Targeted overexpression of elafin protects mice against cardiac dysfunction and mortality following viral myocarditis.

Authors:  S H Zaidi; C C Hui; A Y Cheah; X M You; M Husain; M Rabinovitch
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

6.  Nucleocytoplasmic traffic disorder induced by cardioviruses.

Authors:  Peter V Lidsky; Stanleyson Hato; Maryana V Bardina; Alexei G Aminev; Ann C Palmenberg; Eugene V Sheval; Vladimir Y Polyakov; Frank J M van Kuppeveld; Vadim I Agol
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 7.  Picornavirus nonstructural proteins: emerging roles in virus replication and inhibition of host cell functions.

Authors:  A G Porter
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

8.  Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores.

Authors:  George A Belov; Peter V Lidsky; Olga V Mikitas; Denise Egger; Konstantin A Lukyanov; Kurt Bienz; Vadim I Agol
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Genetic selection of poliovirus 2Apro-binding peptides.

Authors:  I Ventoso; A Barco; L Carrasco
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Calpain 1 and 2 are required for RNA replication of echovirus 1.

Authors:  Paula Upla; Varpu Marjomäki; Liisa Nissinen; Camilla Nylund; Matti Waris; Timo Hyypiä; Jyrki Heino
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.